NCT07260084已完成不适用
Prognostic Impact of Frailty in Cardiogenic Shock: Nationwide Cohort Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 207,419
- 主要终点
- In-hospital all-cause mortality
研究概览
简要总结
The goal of this observational study is to show prognostic impact of frailty in cardiogenic shock according to age. The main questions it aims to answer are:
- Can frailty successfully predict outcomes in cardiogenic shock?
- Whether the impact of frailty would differ with age in cardiogenic shock?
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults aged ≥18 years who were admitted to the intensive care unit (ICU) of tertiary hospitals and were diagnosed with CS
排除标准
- •Patients diagnosed with anaphylaxis
- •Patients with a documented history of shock in the year before the index admission
结局指标
主要结局
In-hospital all-cause mortality
时间窗: During index hospitalization for cardiogenic shock (up to hospital discharge)
Death from any cause occurring during the index hospitalization for cardiogenic shock. Number of participants with the event was measured
次要结局
- Heart failure-related rehospitalization(From index hospitalization until 15 years of follow-up.)
- Cognitive impairment(From index hospitalization until 15 years of follow-up.)
- Mental health problems(From index hospitalization until 15 years of follow-up.)
- Long-term all-cause mortality(From index hospitalization until 15 years of follow-up.)
研究者
Ki Hong Choi
Professor
Samsung Medical Center
相似试验
招募中
不适用
Prognostic Value of the Rockwood Clinical Frailty Score in Cardiogenic ShockCardiogenic ShockNCT06692855University Hospital, Strasbourg, France300
招募中
2 期
Prospective, randomized study concerning personalized medicine with Pentaglobin® after interventional infectious source control in peritonitis patientssepsis2024-513526-27-00Universitaetsklinikum Aachen AöR200
进行中（未招募）
不适用
Survival of patients with acute heart failure in need of intravenous inotropic support; a multicentre parallel- group, randomised, double- blind, double- dummy study of levosimendan versus dobutamine in patients with acute heart failure. - The SURVIVE studyEUCTR2004-001225-16-ATOrion Pharma700
已完成
不适用
Observational cohort study of acute heart failure in Yokohama, Yokohama Acute Heart Failure (YAHF) registryAcute heart failureJPRN-UMIN000010161Yokohama City University Medical Center450
已完成
不适用
The prognostic factor in heart failure patientsHeart failureJPRN-UMIN000022205Jichi Medical University School of Medicine, Division of Cardiovascular Medicine, Department of Medicine800